Microbiology Testing Market Size 2024-2028

The microbiology testing market size is estimated to grow by USD 3.96 billion at a CAGR of 11.62% between 2023 and 2028. Market expansion relies on various factors, such as the rising prevalence of infectious diseases and cancer, growing efforts to enhance rapid diagnostics for infectious diseases, and increasing demand for analytical instruments within the food and beverage sectors. These elements collectively shape the trajectory of market growth, reflecting a combination of healthcare needs, technological advancements, and industry trends. The increasing incidence of infectious diseases and cancer underscores the demand for advanced diagnostic tools and treatment solutions to address public health challenges effectively. Simultaneously, initiatives aimed at improving infectious diseases diagnostics highlight the importance of timely and accurate detection for disease management and containment. Additionally, the rising demand for analytical instruments in the food and beverage industries underscores the need for quality control and safety assurance in food production processes. Thus, the interplay of these factors delineates the landscape for the anticipated expansion of the market. It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.

What will be the size of the Microbiology Testing Market During the Forecast Period?

To learn more about this Microbiology Testing market report, Download Market Research Report Sample PDF

Market Dynamics

The market plays a crucial role in modern healthcare infrastructure, offering essential services like microbiology testing services. Clinical microbiology laboratories rely on state-of-the-art instruments, medical devices, and testing supplies for accurate routine tests and early disease diagnosis. However, challenges such as backorders and staffing shortages hinder operations, emphasizing the need for streamlined laboratory reimbursement and sufficient trained technologists. With a focus on antimicrobial susceptibility testing and identification of etiologic agents, the market contributes to effective patient management and disease control. Supported by private-public funding and initiatives like PubMed Central and UNAIDS, the Microbiology Testing market continues to advance healthcare outcomes globally.

Key Market Driver

The increasing incidence of infectious diseases and cancer is notably driving market growth. The prevalence of infectious diseases such as tuberculosis, HIV, pneumonia, and malaria has increased. Diseases like HIV attacks eventually destroy the immune system, resulting in AIDS, although this progression takes years. Thus, the body cannot defend itself against germs and infections as the immune system is compromised. There has been an increase in awareness programs related to infectious diseases such as HIV, cancer, tuberculosis, and pneumonia to encourage preventive healthcare or early diagnosis for improved treatment outcomes.

For instance, the Aid for AIDS program understands the needs of patients and provides them with the required treatments and tools to lead normal lives. With the global burden of these diseases increasing, the demand for rapid microbiology techniques for faster and more accurate microbial screening, identification, and testing against pathogens is expected to grow significantly. Such factors will boost the market during the forecast period.

Significant Market Trends

The rise in food safety concerns is an emerging trend in the market. Food products are made up of plants and animals, and they usually contain a variety of microorganisms. Microbiomes from natural sources may come in contact with and contaminate food during manufacturing and consumption processes. Furthermore, microbial contamination of food items causes spoilage, which can result in foodborne illnesses if consumed. Foodborne illnesses are regarded as serious public health issues around the world. To limit harmful infectious disease growth, microbial identification products and services are used to inspect the quality of newly released food products.

Further, the importance of food safety as a measure to prevent the spread of diseases is growing. In many countries, the government is significantly focusing on food-related safety standards. Regulatory authorities are also constantly updating food safety regulations to ensure that the food and beverage industries deliver the optimum safety and quality of food products to consumers. Thus, owing to such factors the global market is expected to witness growth during the forecast period.

Major Market Challenge

Inadequate healthcare services in developing regions is a major challenge impeding market growth. Many people in several developing regions do not have the required knowledge or access to healthcare facilities to stay healthy. Also, the lack of financial resources is a major obstacle to public health, leading to an increase in infectious diseases, which is a significant public health concern. Moreover, healthcare systems in most developing countries are plagued by the lack of skilled personnel, making it difficult for them to provide access to quality healthcare services such as microbiology testing.

Moreover, countries such as Afghanistan and Bangladesh are grappling with the lack of technology and the appropriate policies to enable the delivery of healthcare services. The stigma or misconception about the gravity of conditions such as STDs further discourages any form of testing, including microbiology testing and the subsequent treatment of infectious diseases. Hence, the abovementioned factors will hinder the growth of the market during the forecast period.

Key Market Customer Landscape

The microbiology testing market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Market Customer Landscape

Who are the Major Microbiology Testing Market Companies?

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

Institut Merieux - The company develops new approaches in the fields of diagnostics, immunotherapy, food safety, and nutrition.  The key offerings of the company include microbiology testing solutions. 

The microbiology testing market research report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:

• Abbott Laboratories
• Agilent Technologies Inc.
• Becton Dickinson and Co.
• Bio Rad Laboratories Inc.
• Bruker Corp.
• Charles River Laboratories International Inc.
• Creative Diagnostics
• Danaher Corp.
• Don Whitley Scientific Ltd.
• Euroclone SpA
• F. Hoffmann La Roche Ltd.
• Hologic Inc.
• Kypha Inc.
• Liofilchem Srl
• Merck KGaA

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, robust, tentative, and weak.

Market Segmentation

By Product

The market share growth by the traditional segment will be significant during the forecast period. Microscopy, antigen detection, serology, and culture are typically used in traditional microbiology testing.

Get a glance at the market contribution of various segments. Request Market Research Report Sample PDF

The traditional segment was valued at USD 2.47 billion in 2018. Microscopy typically provides a presumptive diagnosis that needs to be confirmed with additional testing modalities, even though, in many situations, it may serve as the gold standard for diagnosis, such as with malaria or stool parasites, which can be diagnosed by stool testing. Monoclonal antibodies targeted against particular antigens are typically used in antigen detection techniques, and modalities include ELISA and tagged immune microscopy. Furthermore, the foundation of serology testing is the identification of an infection-related host humoral response. This can be extremely specific in some circumstances, whereas in others, cross-reactivity and nonspecific antibodies lead to high rates of false positives. Culture is the main tool used in traditional testing. Clinical specimens are inoculated on various media and then incubated in the case of bacteria and fungi. Utilizing selective and differentiating media may enable improved identification and point toward a possible diagnosis. Typically, species identification is followed by biochemical testing, and antimicrobial susceptibilities are assessed using plating or broth dilution. In general, cultures that are positive signify a gold standard diagnosis. Such benefits are expected to drive the market growth of the traditional method segment of the global market during the forecast period.

By Region

For more insights on the market share of various regions, Request Market Research Report Sample PDF

North America is estimated to contribute 38% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. North America was the largest revenue contributor to the global market in 2023. The growing focus on drug and vaccine discovery and development, recent advances in biotechnology and pharmaceutical research, and the presence of several companies in the country offering a wide range of microbiology testing products are aiding the growth of the market. 

Further, the market in North America is led by the US and Canada owing to the increase in focus on drug discovery and development. R&D for drug development and diagnosis of diseases requires microbiology testing. The drug discovery market is expected to grow owing to the emergence of new fatal diseases, the high prevalence of infectious diseases such as respiratory infections and sexually transmitted diseases, and the increased demand for personalized medicines. Therefore, the increase in emphasis on the production of drugs has played a major role in the adoption of microbiology testing in the region. 

Segment Overview

The microbiology testing market research report provides comprehensive data (region wise segment analysis), with forecasts and estimates in "USD Billion" for the period 2024 to 2028, as well as historical data from 2018 to 2022 for the following segments.

• Method Outlook 
  • Traditional
  • Rapid
  • Molecular

• Product Outlook 
  • Consumable
  • Instruments
• End-user Outlook 
  • Hospitals and diagnostic laboratories
  • Pharmaceutical and biotechnology companies
  • Others

• Region Outlook 
  • North America
    • The U.S.
    • Canada
  • Europe
    • The U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia
    • China
    • India
    • Vietnam
    • Others
  • Rest of World
    • Saudi Arabia
    • South Africa
    • Brazil
    • Others

Market Analyst Overview

The market is a cornerstone of healthcare, facilitating environmental monitoring and combating infectious diseases caused by viruses, bacteria, and fungi. With advanced diagnostic methods including molecular biology and immunological assays, it aids in detecting pathogens and ensuring food safety standards. From respiratory diseases to sexually transmitted infections like gonorrhea and chlamydia, microbiology testing is crucial for early detection and effective antimicrobial therapy. Key components such as PCR machines, automated microbial identification systems, and high-throughput testing platforms enable swift analysis in clinical labs and diagnostic centers. Despite challenges like laboratory reimbursement issues, ongoing research supported by organizations like the NIH drives innovations to address the burden of infectious diseases and combat antimicrobial resistance.

Moreover, the Microbiology Testing market continues to evolve, playing a vital role in global health and disease control. The pharmaceuticals industry faces significant challenges with bacterial infections and antibiotic-resistant bacterial strains, impacting healthcare expenditure and supply chains. Point-of-care testing (POCT) has become essential in diagnosing gastrointestinal diseases, bacterial diseases, and fungal diseases. In academic and research institutes, culture-dependent techniques and culture media are crucial for understanding pathogens, including Salmonellas, yeast, and mold. Biochemical reagents and molecular diagnostic reagents facilitate the detection of high-risk (HR) HPV genotypes and low-risk (LR) HPV genotypes related to cervical cancer, vaginal cancer, and other HPV genotypes. Academic collaborations enhance antimicrobial resistance research and the development of next-generation sequencing platforms and real-time PCR systems.

Furthermore, these advancements aid in diagnosing human papillomavirus (HPV) infections, hepatitis B, and hepatitis C. In medical infrastructures like ambulatory surgical centers, microbiology testing equipment,t and sterile and non-pyrogenic medical devices support effective infection control. The integration of high-throughput capabilities and microbiology instruments in laboratory operations improves diagnostic tests for various ailments, including trichomoniasis, syphilis, and periodontal diseases. Healthcare professionals and academic collaborations continue to drive research in epidemiology and antimicrobial resistance, crucial for managing chronic diseases and bloodstream infections.

Request Market Research Report Sample PDF

What are the Key Data Covered in this Market Forecast Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the market growth and forecasting of the market between 2024 and 2028
• Precise estimation of the market size and its contribution to the parent market
• Accurate predictions about upcoming market trends and analysis and changes in consumer behavior
• Growth of the market across Europe, North America, APAC, South America, and Middle East and Africa
• Thorough market growth analysis of the market’s competitive landscape and detailed information about companies
• Comprehensive market analysis and report on the factors that will challenge the market research and growth of market companies

We can help! Our analysts can customize this microbiology testing market research report to meet your requirements. Get in touch